MicroRNAs and apoptosis: implications in the molecular therapy of human disease.
1. MicroRNAs (miRNAs), the small non-coding RNAs of approximately 22 nucleotides, are now recognized as a very large family present throughout the genomes of plants and metazoans. These small transcripts modulate protein expression by binding to complementary or partially complementary target protein-coding mRNAs and targeting them for degradation or translational inhibition. 2. The discovery of miRNAs has revolutionized our understanding of the mechanisms that regulate gene expression, with the addition of an entirely novel level of regulatory control. Considerable information on miRNAs has been accumulated in this rapidly evolving research field. We now know that miRNAs play pivotal roles in diverse processes, such as development and differentiation, control of cell proliferation and death, stress response and metabolism. Indeed, aberrant miRNA expression has been documented in human disease as well as in animal models, with evidence for a causative role in tumourigenesis. 3. One of the most active fields of miRNA research is miRNA regulation of apoptosis, a programmed cell death implicated in many human diseases, such as cancer, Alzheimer's disease, hypertrophy and heart failure. Thus far, nearly 30 of 500 human miRNAs have been validated experimentally to regulate apoptosis; this number is likely to increase with future studies. 4. The present review provides a comprehensive summary and analysis of the currently available data, focusing on the transcriptional controls, target genes and signalling pathways linking the apoptosis-regulating miRNAs and apoptotic cell death.
Yang
Bao-Feng
BF
Department of Pharmacology (State Province Key Laboratories of Biomedicine-Pharmaceutics of China), Cardiovascular Research Institute, Harbin Medical University, Harbin, Heilongjiang, China. yangbf@ems.hrbmu.edu.cn
Lu
Yan-Jie
YJ
Wang
Zhi-Guo
ZG
D000818:Animals; D017209:Apoptosis / Q000235:genetics*; D004194:Disease / Q000235:genetics; D016503:Drug Delivery Systems / Q000379:methods; D005786:Gene Expression Regulation / Q000502:physiology; D018390:Gene Targeting / Q000379:methods; D006801:Humans; D035683:MicroRNAs / Q000235:genetics / Q000502:physiology*; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology; D013812:Therapeutics / Q000379:methods* / Q000639:trends
D035683:MicroRNAs